Thyroid hormone receptor β (THRB, T3R-beta1) is frequently mutated and downregulated in human cancers such as breast, lung, and thyroid cancer, suggesting its potential role as a tumor suppressor [46]. This evidence concerns the gene THRB and thyroid gland carcinoma.